Gland Pharma Limited (BOM:543245)
India flag India · Delayed Price · Currency is INR
1,815.30
-50.75 (-2.72%)
At close: Feb 12, 2026

Gland Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
293,398262,358303,932208,882537,705405,432
Market Cap Growth
23.65%-13.68%45.50%-61.15%32.63%-
Enterprise Value
264,402236,321286,055175,977508,469390,204
Last Close Price
1779.651577.511806.281244.073205.932429.88
PE Ratio
34.6337.5639.3526.7444.3840.67
PS Ratio
4.804.675.375.7612.2211.71
PB Ratio
3.072.873.482.637.516.87
P/TBV Ratio
3.202.983.632.637.536.87
P/FCF Ratio
-49.4850.08146.03192.42107.78
P/OCF Ratio
-28.6830.4957.3968.0067.02
EV/Sales Ratio
4.334.215.054.8611.5511.27
EV/EBITDA Ratio
18.3919.1922.0617.0733.6729.97
EV/EBIT Ratio
25.5627.1029.4519.9036.3232.42
EV/FCF Ratio
-44.5747.14123.03181.96103.74
Debt / Equity Ratio
0.030.030.040.000.000.00
Debt / EBITDA Ratio
0.210.250.280.000.000.00
Debt / FCF Ratio
-0.590.610.030.020.01
Net Debt / Equity Ratio
-0.30-0.29-0.18-0.47-0.45-0.51
Net Debt / EBITDA Ratio
-2.04-2.14-1.21-3.64-2.15-2.30
Net Debt / FCF Ratio
--4.98-2.58-26.27-11.60-7.97
Asset Turnover
-0.510.580.440.610.65
Inventory Turnover
-1.441.401.161.791.56
Quick Ratio
-3.012.616.587.807.31
Current Ratio
-4.344.049.4610.0610.00
Return on Equity (ROE)
-7.82%9.26%10.33%18.55%20.88%
Return on Assets (ROA)
-4.98%6.25%6.65%12.21%14.22%
Return on Invested Capital (ROIC)
10.55%8.39%11.67%16.14%30.73%34.27%
Return on Capital Employed (ROCE)
-9.00%10.50%11.00%19.30%20.10%
Earnings Yield
2.89%2.66%2.54%3.74%2.25%2.46%
FCF Yield
-2.02%2.00%0.69%0.52%0.93%
Dividend Yield
0.97%1.14%1.11%---
Payout Ratio
-47.17%----
Buyback Yield / Dilution
-0.02%-0.01%-0.03%-0.09%-3.96%-2.15%
Total Shareholder Return
0.96%1.13%1.07%-0.09%-3.96%-2.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.